-46%

est. 2Y upside i

HealthcareSeries D+

Truepill is the leading telehealth fulfillment and patient engagement platform.

Rank

#3704

Sector

HealthTech

Est. Liquidity

~3Y

Data Quality

Data: Medium

Truepill has been acquired by LetsGetChecked for $525M, which includes $25M in cash, stock, and up to $200M in earnouts tied to revenue milestones.

Last updated: March 10, 2026

Bull (20%)+38%

Truepill's integration into LetsGetChecked is highly successful, exceeding the $200M earn-out milestones and driving significant synergies. This robust performance of the Truepill business unit contributes to a substantial increase in LetsGetChecked's overall valuation, leading to a combined value of $725M for Truepill's component, offering a 38% upside from the acquisition price.

Base (50%)+19%

The acquisition for $525M closes as planned, and Truepill achieves a portion of the $200M earn-out (e.g., $100M) tied to revenue milestones. Truepill's operations stabilize within LetsGetChecked, contributing steadily to the combined entity, resulting in a total value of $625M for Truepill's component, representing a 19% upside from the acquisition price.

Bear (30%)-30%

Truepill's business unit struggles with integration challenges, misses earn-out targets, or faces further regulatory issues (e.g., DEA scrutiny). This underperformance leads to a write-down of its value within LetsGetChecked, resulting in a 30% downside from the $525M acquisition price, bringing its effective value to $367.5M.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Funding Intensity

61%

Truepill raised $322M in total funding against an acquisition valuation of $525M, meaning preferred shareholders likely received $322M, leaving $203M for common shareholders.

Dilution Risk

high

While Truepill-specific dilution is no longer a factor post-acquisition, LetsGetChecked raised $150M via a convertible note to finance the deal, indicating potential future dilution for equity holders in the combined entity.

Secondary Liquidity

none

As Truepill has been acquired and is now a subsidiary, there is no independent secondary market for its equity; any liquidity would be tied to LetsGetChecked's future events as a private company.

Questions to Ask at the Interview

Strategic questions based on Truepill's data — designed to show you've done your homework.

  • 1

    “Given Truepill's acquisition by LetsGetChecked, how is the company structuring equity for new hires, and what are the specific mechanisms for employees to benefit from the $200M earn-out potential?”

  • 2

    “With Truepill now operating as a subsidiary, what are the key strategic priorities for integrating Truepill's digital pharmacy and telehealth platforms with LetsGetChecked's at-home testing services, and what are the primary challenges foreseen?”

  • 3

    “Considering Truepill's past financial difficulties and regulatory scrutiny, what measures are being implemented to ensure operational stability and compliance within the combined entity, and how will these impact growth projections over the next two years?”

Community

Valuation Sentiment

Our model estimates -46% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.